Medpace Holdings Inc. (NASDAQ:MEDP) posted better-than-expected third-quarter earnings on Thursday.The clinical contract research organization reported earnings of $3.86, beating the consensus of$3.52. Sales reached $659.9 million, surpassing the consensus of$640.99 million. Sales increased 23.7% year over year. On a constant currency basis, revenue jumped 23.4%.Medpace raised fiscal 2025 earnings per share from $13.76-$14.53 to $14.60-$14.86 versus consensus of $14.07. The consensus increased 2025 sales ...